False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector.
作者信息
De Ravin Suk See, Gray John T, Throm Robert E, Spindler Jon, Kearney Mary, Wu Xiaolin, Coffin John M, Hughes Stephen H, Malderelli Frank, Sorrentino Brian P, Malech Harry L
机构信息
Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
St Jude Children's Research Hospital, Memphis, Tennessee, USA.
出版信息
Mol Ther. 2014 Feb;22(2):244-245. doi: 10.1038/mt.2013.296.
Abstract
摘要
相似文献
1
False-positive HIV PCR test following ex vivo lentiviral gene transfer treatment of X-linked severe combined immunodeficiency vector.X连锁重症联合免疫缺陷载体的慢病毒基因转移治疗后HIV PCR检测出现假阳性
Mol Ther. 2014 Feb;22(2):244-245. doi: 10.1038/mt.2013.296.
2
Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.慢病毒造血干细胞基因疗法治疗X连锁重症联合免疫缺陷病
Sci Transl Med. 2016 Apr 20;8(335):335ra57. doi: 10.1126/scitranslmed.aad8856.
3
Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.用一种由稳定细胞系在临床规模生产的自失活慢病毒载体转导人CD34 + 重建造血细胞用于X连锁重症联合免疫缺陷病（SCID-X1）的治疗
Hum Gene Ther Methods. 2012 Oct;23(5):297-308. doi: 10.1089/hgtb.2012.150. Epub 2012 Nov 7.
4
Lymphomagenesis in SCID-X1 mice following lentivirus-mediated phenotype correction independent of insertional mutagenesis and gammac overexpression.SCID-X1 小鼠中的淋巴瘤发生与反转录病毒介导的表型校正相关，与插入突变和 γc 过表达无关。
Mol Ther. 2010 May;18(5):965-76. doi: 10.1038/mt.2010.50. Epub 2010 Mar 30.
5
Quantitative shearing linear amplification polymerase chain reaction: an improved method for quantifying lentiviral vector insertion sites in transplanted hematopoietic cell systems.定量剪切线性扩增聚合酶链反应：一种用于定量移植造血细胞系统中慢病毒载体插入位点的改进方法。
Hum Gene Ther Methods. 2015 Feb;26(1):4-12. doi: 10.1089/hgtb.2014.122. Epub 2015 Feb 5.
6
Promoter competition for gene therapy of SCID-X1.用于X连锁重症联合免疫缺陷（SCID-X1）基因治疗的启动子竞争
Hum Gene Ther. 2011 Mar;22(3):255-6. doi: 10.1089/hum.2011.2280.
7
Progress in gene therapy for primary immunodeficiencies using lentiviral vectors.使用慢病毒载体进行原发性免疫缺陷基因治疗的进展。
Curr Opin Allergy Clin Immunol. 2014 Dec;14(6):527-34. doi: 10.1097/ACI.0000000000000114.
8
Delivering genes with human immunodeficiency virus-derived vehicles: still state-of-the-art after 25 years.用人类免疫缺陷病毒载体递送基因：25 年后仍处于最先进水平。
J Biomed Sci. 2022 Oct 9;29(1):79. doi: 10.1186/s12929-022-00865-4.
9
Trial watch: Self-inactivating gene-therapy vector alleviates safety concerns.试验观察：自我失活基因治疗载体减轻了安全担忧。
Nat Rev Drug Discov. 2014 Dec;13(12):879. doi: 10.1038/nrd4495. Epub 2014 Nov 14.
10
Site-specific gene insertion mediated by a Cre-loxP-carrying lentiviral vector.携带 Cre-loxP 的慢病毒载体介导的位点特异性基因插入。
Mol Ther. 2010 Oct;18(10):1814-21. doi: 10.1038/mt.2010.150. Epub 2010 Jul 13.
引用本文的文献
1
False-positive human immunodeficiency virus nuclear acid amplification technique testing following therapy with transgenic T cell receptor cellular therapy for synovial sarcoma.滑膜肉瘤经转基因T细胞受体细胞疗法治疗后人类免疫缺陷病毒核酸扩增技术检测出现假阳性
Bone Marrow Transplant. 2024 Aug;59(8):1190-1192. doi: 10.1038/s41409-024-02307-1. Epub 2024 May 17.
2
Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia.经慢病毒基因治疗治疗后出现野生型 HIV 感染β-地中海贫血。
Blood Adv. 2021 Jul 13;5(13):2701-2706. doi: 10.1182/bloodadvances.2020003680.
3
Complete remission in refractory acute lymphoblastic leukemia using blinatumomab after failure of response to CD-19 chimeric antigen receptor T-cell therapy.在对CD-19嵌合抗原受体T细胞疗法反应失败后，使用博纳吐单抗使难治性急性淋巴细胞白血病完全缓解。
Clin Case Rep. 2020 May 28;8(9):1678-1681. doi: 10.1002/ccr3.2918. eCollection 2020 Sep.
4
False-Positive Results for Human Immunodeficiency Virus Type 1 Nucleic Acid Amplification Testing in Chimeric Antigen Receptor T Cell Therapy.嵌合抗原受体 T 细胞治疗中人类免疫缺陷病毒 1 型核酸扩增检测的假阳性结果。
J Clin Microbiol. 2019 Dec 23;58(1). doi: 10.1128/JCM.01420-19.
5
Myths in the laboratory diagnosis of HIV infection.HIV感染实验室诊断中的误区。
Emerg Microbes Infect. 2019;8(1):1240-1242. doi: 10.1080/22221751.2019.1656550.
6
False-positive results with select HIV-1 NAT methods following lentivirus-based tisagenlecleucel therapy.基于慢病毒的替沙格赛基因疗法后，采用某些HIV-1核酸检测方法会出现假阳性结果。
Blood. 2018 Jun 7;131(23):2596-2598. doi: 10.1182/blood-2017-12-822940. Epub 2018 Apr 18.
7
False-positive HIV nucleic acid amplification testing during CAR T-cell therapy.嵌合抗原受体T细胞疗法期间的HIV核酸扩增检测假阳性
Diagn Microbiol Infect Dis. 2017 Aug;88(4):305-307. doi: 10.1016/j.diagmicrobio.2017.05.016. Epub 2017 Jun 3.
8
Gene Therapy for the Treatment of Primary Immune Deficiencies.用于治疗原发性免疫缺陷的基因疗法。
Curr Allergy Asthma Rep. 2016 May;16(5):39. doi: 10.1007/s11882-016-0615-8.
9
Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?X连锁重症联合免疫缺陷的基因治疗：我们目前的进展如何？
Hum Gene Ther. 2016 Feb;27(2):108-16. doi: 10.1089/hum.2015.137.
10
Gene transfer of two entry inhibitors protects CD4⁺ T cell from HIV-1 infection in humanized mice.两种进入抑制剂的基因转移可保护人源化小鼠中的CD4⁺ T细胞免受HIV-1感染。
Gene Ther. 2016 Feb;23(2):144-50. doi: 10.1038/gt.2015.101. Epub 2015 Oct 21.
本文引用的文献
1
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.慢病毒造血干细胞基因治疗有益于脑苷脂沉积病。
Science. 2013 Aug 23;341(6148):1233158. doi: 10.1126/science.1233158. Epub 2013 Jul 11.
2
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.慢病毒造血干细胞基因治疗 Wiskott-Aldrich 综合征患者。
Science. 2013 Aug 23;341(6148):1233151. doi: 10.1126/science.1233151. Epub 2013 Jul 11.
3
Tracking replication-competent HIV reservoirs in infected individuals.追踪感染个体中具有复制能力的 HIV 储存库。
Curr Opin HIV AIDS. 2013 Mar;8(2):111-6. doi: 10.1097/COH.0b013e32835d6e1c.
4
Transduction of human CD34+ repopulating cells with a self-inactivating lentiviral vector for SCID-X1 produced at clinical scale by a stable cell line.用一种由稳定细胞系在临床规模生产的自失活慢病毒载体转导人CD34 + 重建造血细胞用于X连锁重症联合免疫缺陷病（SCID-X1）的治疗
Hum Gene Ther Methods. 2012 Oct;23(5):297-308. doi: 10.1089/hgtb.2012.150. Epub 2012 Nov 7.
5
Generation of an HIV-1-resistant immune system with CD34(+) hematopoietic stem cells transduced with a triple-combination anti-HIV lentiviral vector.用三重组合抗 HIV 慢病毒载体转导的 CD34(+)造血干细胞生成抗 HIV-1 免疫系统。
J Virol. 2012 May;86(10):5719-29. doi: 10.1128/JVI.06300-11. Epub 2012 Mar 7.
6
Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia.嵌合抗原受体修饰的 T 细胞治疗慢性淋巴细胞白血病。
N Engl J Med. 2011 Aug 25;365(8):725-33. doi: 10.1056/NEJMoa1103849. Epub 2011 Aug 10.
7
Chronic granulomatous disease: overview and hematopoietic stem cell transplantation.慢性肉芽肿病：概述与造血干细胞移植。
J Allergy Clin Immunol. 2011 Jun;127(6):1319-26; quiz 1327-8. doi: 10.1016/j.jaci.2011.03.028. Epub 2011 Apr 17.
8
Replication-competent lentivirus analysis of clinical grade vector products.临床级载体产品的复制型慢病毒分析。
Mol Ther. 2011 Mar;19(3):557-66. doi: 10.1038/mt.2010.278. Epub 2010 Dec 21.
9
RNA-based gene therapy for HIV with lentiviral vector-modified CD34(+) cells in patients undergoing transplantation for AIDS-related lymphoma.用慢病毒载体修饰的 CD34(+)细胞进行基于 RNA 的基因治疗，治疗因 AIDS 相关淋巴瘤而接受移植的患者中的 HIV。
Sci Transl Med. 2010 Jun 16;2(36):36ra43. doi: 10.1126/scitranslmed.3000931.
10
A self-inactivating lentiviral vector for SCID-X1 gene therapy that does not activate LMO2 expression in human T cells.一种用于 SCID-X1 基因治疗的自失活慢病毒载体，不会在人 T 细胞中激活 LMO2 表达。
Blood. 2010 Aug 12;116(6):900-8. doi: 10.1182/blood-2009-10-250209. Epub 2010 May 10.
Zotero 插件